Maladies inflammatoires de l'intestin [Main therapeutic advances in IBD in 2008]
| Data(s) |
2009
|
|---|---|
| Resumo |
A coimmunosuppression with azathioprine or methotrexate in addition to infliximab does not improve the therapeutic efficacy in Crohn's disease but increase the risks of infectious complications and neoplasia. |
| Identificador |
http://serval.unil.ch/?id=serval:BIB_2DA4F8AFD844 isbn:1660-9379 pmid:19271429 |
| Idioma(s) |
fr |
| Fonte |
Revue Médicale Suisse, vol. 5, no. 187, pp. 185-194 |
| Palavras-Chave | #Chemoprevention; Gastrointestinal Agents; Humans; Inflammatory Bowel Diseases; Tumor Necrosis Factor-alpha |
| Tipo |
info:eu-repo/semantics/article article |
